₹201.6*
MRP ₹224
10% off
₹190.4*
MRP ₹224
15% CB
₹33.6 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Available Offers
PHARMA1818% OFF, applicable on orders > INR 2999
PHARMA1010% OFF, applicable on orders > INR 799
PHARMA2020% OFF, applicable on orders > INR 5499
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Extra Savings
Manufacturer/Marketer :
Lloyd Healthcare Pvt Ltd
Consume Type :
ORAL
Return Policy :
3 Days Returnable
Expires on or after :
Jan-27
Drug-Drug Interactions
TelmisartanAliskiren
Critical
chlorthalidoneCisapride
Critical
Drug-Drug Interactions
Login/Sign Up
TelmisartanAliskiren
Critical
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Co-administration of Aliskiren with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
chlorthalidoneCisapride
Critical
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
TelmisartanSpironolactone
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Taking spironolactone with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
TelmisartanPotassium iodide
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Taking Potassium Iodide with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Taking Potassium Iodide with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
TelmisartanEnalapril
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Coadministration of enalapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
TelmisartanEnalapril
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Co-administration of Enalapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can increase the risk of kidney failure, low blood pressure, and high potassium levels.
How to manage the interaction:
Although there is a possible interaction between Enalapril and Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's, you can take these medicines together if prescribed by your doctor. However, contact a doctor if you experience nausea, vomiting, weakness, tingling of the hands and feet, or feelings of heaviness in the legs, so it's important to seek medical help. Do not stop using any medications without a doctor's advice.
Co-administration of Enalapril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can increase the risk of kidney failure, low blood pressure, and high potassium levels.
How to manage the interaction:
Although there is a possible interaction between Enalapril and Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's, you can take these medicines together if prescribed by your doctor. However, contact a doctor if you experience nausea, vomiting, weakness, tingling of the hands and feet, or feelings of heaviness in the legs, so it's important to seek medical help. Do not stop using any medications without a doctor's advice.
TelmisartanPerindopril
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Taking perindopril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanLithium
Severe
How does the drug interact with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's:
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Bylenta Trio 40 mg/10 mg/12.5 mg Tablet 15's can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet Substitute
Cilacar TC 12.5 Tablet 10's
by AYUR
₹23.27per tabletTsart Trio 12.5 Tablet 10's
₹21.47per tabletDilnip-Trio Tablet 10's
by AYUR
₹21.78per tabletTelmikind Trio 12.5 Tablet 10's
by AYUR
₹11.97per tabletTelista Trio CL 12.5 mg Tablet 15's
by AYUR
₹22.77per tablet
Product Substitutes
Alcohol
Unsafe
Avoid consumption of alcohol with Bylenta Trio 40 mg/10 mg/12.5 mg Tablet as it may increase the risk of low blood pressure and cause adverse effects such as dizziness, fainting, light-headedness, or headache.
Pregnancy
Unsafe
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet is not recommended for pregnant women as it may cause serious harm to the unborn baby. Please consult a doctor if you are pregnant.
Breast Feeding
Unsafe
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may be excreted in human milk and harm the baby. Therefore, avoid taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet if you are breastfeeding and consult a doctor.
Driving
Caution
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet may cause dizziness or tiredness in some people. Therefore, avoid driving if you feel dizzy or tired after taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet .
Liver
Caution
Take Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required. Avoid taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet if you have severe liver disease.
Kidney
Caution
Take Bylenta Trio 40 mg/10 mg/12.5 mg Tablet with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required. Avoid taking Bylenta Trio 40 mg/10 mg/12.5 mg Tablet if you have severe kidney disease.
Children
Unsafe
Bylenta Trio 40 mg/10 mg/12.5 mg Tablet is not recommended for children below 18 years as safety and effectiveness is not established.
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
